Media - Abzena

Events

References

Addressing the Challenges of Bioconjugate Medicines

The continuing advancements in bioconjugate medicines from delivery of potent cytotoxins to vaccine-, oligonucleotide-,[...] Read more

News

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of[...] Read more

Abzena selected by Immunome to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment

Exton, PA and San Diego, CA – February 3, 2021 – Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing[...] Read more

Posts

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of[...] Read more

Interested in our services? Get In Touch